Literature DB >> 29322178

Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.

Elisabeth Castellanos1, Adrià Plana2, Cristina Carrato3, Meritxell Carrió1, Inma Rosas1, Emilio Amilibia4, Francesc Roca-Ribas4, Cristina Hostalot5, Alicia Castillo6, Andrea Ros6, Ariadna Quer3, Juan Luis Becerra7, Hector Salvador8, Conxi Lázaro9, Ignacio Blanco6, Eduard Serra1, Isabel Bielsa2.   

Abstract

Importance: Neurofibromatosis type 2 (NF2) is a devastating genetic condition characterized by the development of multiple tumors of the nervous system. An early diagnosis of individuals with NF2 would facilitate treatment and reduction of disease impact because most severe effects of the disease do not usually develop before adolescence. Little attention has traditionally been paid to dermatological signs in NF2. However, skin plaques are commonly seen in patients with NF2, normally appearing either at birth or early childhood, providing an opportunity for early NF2 detection and testing. Objective: To determine the clinical utility of skin plaque identification and characterization in children for reaching an early diagnosis of patients with NF2 and to evaluate their molecular pathogenesis and their use in the genetic diagnostics of NF2. Design, Setting, and Participants: Diagnostic test study by the histological and genetic characterization of skin plaques from patients with NF2. Patients were 7 individuals with NF2 or clinical suspicion of NF2 treated at the Spanish Reference Center on Phakomatoses. Main Outcomes and Measures: Histological evaluation of all skin plaques was performed. Fresh skin plaques were cultured to obtain Schwann cells and the NF2 gene was genetically analyzed. For all 7 patients, NF2 clinical history was reviewed.
Results: In all 7 patients (4 male and 3 female), all skin plaques analyzed were histologically characterized as plexiform schwannomas. Genetic analysis of primary Schwann cell cultures derived from them allowed the identification of a constitutional and a somatic NF2 mutation. Genetic testing allowed the early diagnosis of NF2 in a child only exhibiting the presence of skin plaques. Most of the patients with NF2 analyzed had an early presentation of skin plaques and a severe NF2 phenotype. Conclusions and Relevance: This work emphasizes the clinical utility of a careful dermatological inspection and the correct identification of skin plaques in children for an early diagnosis of NF2. We show for the first time that Schwann cells derived from skin plaque plexiform schwannomas bear the double inactivation of the NF2 gene and thus constitute an excellent source of tissue for genetic testing, especially in the context of mosaicism.

Entities:  

Mesh:

Year:  2018        PMID: 29322178      PMCID: PMC5885846          DOI: 10.1001/jamadermatol.2017.5464

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  14 in total

1.  Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.

Authors:  Takehiko Miyakawa; Noriaki Kamada; Takashi Kobayashi; Keiko Hirano; Katsunori Fujii; Yoshitaro Sasahara; Yuichiro Nagai; Hiroshi Shinkai
Journal:  J Dermatol       Date:  2007-01       Impact factor: 4.005

2.  Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.

Authors:  L Kluwe; R E Friedrich; C Hagel; M Lindenau; V F Mautner
Journal:  J Invest Dermatol       Date:  2000-05       Impact factor: 8.551

3.  Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.

Authors:  M Ruggieri; P Iannetti; A Polizzi; I La Mantia; A Spalice; O Giliberto; N Platania; A L Gabriele; V Albanese; L Pavone
Journal:  Neuropediatrics       Date:  2005-02       Impact factor: 1.947

4.  Skin abnormalities in neurofibromatosis 2.

Authors:  V F Mautner; M Lindenau; M E Baser; L Kluwe; J Gottschalk
Journal:  Arch Dermatol       Date:  1997-12

Review 5.  Neurofibromatosis type 2 (NF2): diagnosis and management.

Authors:  Simon K W Lloyd; D Gareth R Evans
Journal:  Handb Clin Neurol       Date:  2013

Review 6.  Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.

Authors:  Martino Ruggieri; Andrea Domenico Praticò; Dafydd Gareth Evans
Journal:  Semin Pediatr Neurol       Date:  2015-10-28       Impact factor: 1.636

7.  Cutaneous plexiform schwannoma associated with neurofibromatosis type 2.

Authors:  J F Val-Bernal; J Figols; A Vázquez-Barquero
Journal:  Cancer       Date:  1995-10-01       Impact factor: 6.860

8.  Neurofibromatosis 2 in the pediatric population.

Authors:  Fabio Nunes; Mia MacCollin
Journal:  J Child Neurol       Date:  2003-10       Impact factor: 1.987

9.  Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients.

Authors:  Adam Hexter; Adrian Jones; Harry Joe; Laura Heap; Miriam J Smith; Andrew J Wallace; Dorothy Halliday; Allyson Parry; Amy Taylor; Lucy Raymond; Adam Shaw; Shazia Afridi; Rupert Obholzer; Patrick Axon; Andrew T King; Jan M Friedman; D Gareth R Evans
Journal:  J Med Genet       Date:  2015-08-14       Impact factor: 6.318

10.  A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.

Authors:  Elisabeth Castellanos; Bernat Gel; Inma Rosas; Eva Tornero; Sheila Santín; Raquel Pluvinet; Juan Velasco; Lauro Sumoy; Jesús Del Valle; Manuel Perucho; Ignacio Blanco; Matilde Navarro; Joan Brunet; Marta Pineda; Lidia Feliubadaló; Gabi Capellá; Conxi Lázaro; Eduard Serra
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

View more
  5 in total

1.  Missing Affiliation.

Authors: 
Journal:  JAMA Dermatol       Date:  2018-07-01       Impact factor: 10.282

2.  Visceral plexiform schwannoma: A case series.

Authors:  Francesca Destro; Shilpa Sharma; Luciano Maestri; Claudio Vella; Paola Collini; Giovanna Riccipetitoni
Journal:  Mol Clin Oncol       Date:  2020-11-26

3.  Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas.

Authors:  A Plana-Pla; B García; M Munera-Campos; N Catasus; E Serra Arenas; I Blanco; E Castellanos Perez; I Bielsa
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-05-21       Impact factor: 9.228

Review 4.  Review of Pediatric Head and Neck Neoplasms that Raise the Possibility of a Cancer Predisposition Syndrome.

Authors:  Nahir Cortes-Santiago; Kalyani Patel
Journal:  Head Neck Pathol       Date:  2021-03-15

Review 5.  Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.

Authors:  Ryota Tamura
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.